{
  "basic_data": [
    {
      "hpscreg_name": "AIBNi017-A",
      "cell_line_alt_name": "SPGh1-SO75mC2",
      "cell_type": "hiPSC",
      "frozen": "True"
    }
  ],
  "generator": [
    {
      "group": "Australian Institute for Bioengineering and Nanotechnology"
    }
  ],
  "contact": [
    {
      "group": "Wolvetang-AIBN",
      "first_name": "Ernst",
      "last_name": "Wolvetang",
      "name_initials": "J",
      "e_mail": "e.wolvetang@uq.edu.au",
      "phone_number": "Missing"
    }
  ],
  "publications": [
    {
      "doi": "10.1016/j.scr.2022.102917",
      "journal": "Stem Cell Research",
      "title": "Generation of iPSC lines from hereditary spastic paraplegia 56 (SPG56) patients and family members carrying CYP2U1 mutations",
      "first_author": "Hannah C. Leeson",
      "last_author": "Ernst J. Wolvetang",
      "year": "2022",
      "pmid": "Missing"
    }
  ],
  "donor": [
    {
      "age": "A30_34",
      "sex": "Female",
      "disease_name": "Hereditary spastic paraplegia 56 (SPG56)",
      "disease_description": "A rare form of complicated hereditary spastic paraplegia caused by mutations in CYP2U1 gene"
    }
  ],
  "genomic_modifications": [
    {
      "mutation_type": "Hereditary",
      "cytoband": "Missing",
      "delivery_method": "Non-integrative Sendai virus delivery",
      "description": "CYP2U1 heterozygous carrier with Exon 1 deletion: Chr4: 107932113; c.471delC; p.(Ile158fs)",
      "genotype": "Heterozygous carrier c.471delC; p.(Ile158fs)",
      "loci_name": "CYP2U1"
    }
  ],
  "differentiation_results": [
    {
      "cell_type": "Endoderm",
      "show_potency": "True",
      "marker_list": "FOXA2; SOX17; CXCR4",
      "method_used": "qPCR",
      "description": "in vitro directed differentiation"
    },
    {
      "cell_type": "Mesoderm",
      "show_potency": "True",
      "marker_list": "PDGFRA; HAND1; BMP4; RUNX1",
      "method_used": "qPCR",
      "description": "in vitro directed differentiation"
    },
    {
      "cell_type": "Ectoderm",
      "show_potency": "True",
      "marker_list": "OTX2; PAX6; NR2F2; VIMENTIN",
      "method_used": "qPCR",
      "description": "in vitro directed differentiation"
    }
  ],
  "undifferentiated_characterisation": [
    {
      "epi_pluri_score": "Missing",
      "pluri_test_score": "Missing",
      "pluri_novelty_score": "Missing"
    }
  ],
  "genomic_characterisation": [
    {
      "passage_number": "16",
      "karyotype": "Normal",
      "karyotype_method": "SNP array",
      "summary": "SNP array analysis conducted at passage 16 showed normal karyotypes with no unbalanced chromosomal aberrations detected."
    }
  ],
  "induced_derivation": [
    {
      "i_source_cell_type_term": "Fibroblasts",
      "i_source_cell_origin_term": "skin",
      "derivation_year": "2021",
      "non_int_vector": "Sendai virus",
      "non_int_vector_name": "CytoTune-iPS 2.0 Sendai Reprogramming Kit"
    }
  ],
  "embryonic_derivation": [
    {
      "embryo_stage": "Missing",
      "zp_removal_technique": "Missing",
      "trophectoderm_morphology": "Missing",
      "icm_morphology": "Missing",
      "e_preimplant_genetic_diagnosis": "Missing"
    }
  ],
  "ethics": [
    {
      "ethics_number": "UQ HREC 2,019,000,159",
      "approval_date": "Missing",
      "institutional_HREC": "University of Queensland Ethics Committee"
    }
  ],
  "culture_medium": [
    {
      "co2_concentration": "0.05",
      "o2_concentration": "0.21",
      "passage_method": "Enzymatically"
    }
  ]
}